MRK

2024Q2BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-07-30 · Fiscal end 2024-06-30 · Features as of 2024-07-29

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.14
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.5%
IV front—
P/C full—
P/C front—
Features as of2024-07-29

Run-up

Close—
Ret 5d+1.7%
Ret 10d-0.3%
Ret 20d+3.2%
Ret 30d-1.2%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.28Beat
Estimated EPS2.14
Actual revenue
16.1B
Surprise %+6.5%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction-6.7%
Implied vs actual

Implied 1.5%Actual 3.4%

Gap reaction-3.4%
Day result-9.8%
Next-day upNo
Realized / IV2.19×

Post tape

Post 5d-3.6%
Post 10d-0.7%
Post volume35.5M
Vol ×10d5.07×
Vol ×20d5.23×
Post range8.1%